<DOC>
	<DOCNO>NCT03001544</DOCNO>
	<brief_summary>This study design determine safety , pharmacokinetics pharmacodynamics single intravenous dose TS23 healthy adult .</brief_summary>
	<brief_title>Study Safety Biomarker Efficacy TS23 Healthy Volunteer</brief_title>
	<detailed_description>This first-in-human , Phase 1 study safety , pharmacokinetics pharmacodynamics TS23 healthy male volunteers.TS23 monoclonal antibody inactivate alpha 2-antiplasmin . Four dose cohort six subject study single ascend dose trial one clinical center .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Able provide write informed consent Healthy males age 18 year 60 year age Body mass index ≥ 20 ≤ 33 kg/m square Known allergy hypersensitivities blood product derivatives therapeutic protein product excipients component CHO cell Current alcohol drug abuse history alcohol drug abuse Participation trial investigational drug within 90 day prior dose Blood donation 500 mL blood within 90 day prior dose Any history bleeding thrombotic disorder Any history significant cardiac , pulmonary , renal , hepatic , neurologic , immunologic disorder Overthecounter medication , dietary supplement herbal product ( except daily vitamin ) within 14 day drug administration study No prescription medication least 14 day 5halflives , whichever longer , prior study drug administration . Use anticoagulant , fibrinolytic agent nonsteroidal antiinflammatory medicine ( except aspirin dose 82 mg per day le ) 2 week prior study Known hereditary fructosemia ( due sorbitol formulation ) Any previous current monoclonal antibody therapy History trauma surgery within past 60 day plan surgery within 30 day Abnormal baseline laboratory value laboratory value deem clinically significant Investigator Recent history head trauma last 30 day prior receive TS23 Unwillingness inability avoid contact sport activity small risk head facial trauma within 30 day receive TS23 History risk fall ( e.g. , due dementia , frailty , etc . ) Sexually active subject must agree use reliable method birth control ( abstinence , condom , vasectomy ) donate sperm 3 month receive TS23</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>